Showing results (1541-1550 of 1,768) with videos related to

Sort By:
Pageof 177
JAMA Neurology|October 5, 2017
Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial InfarctionWalter N Kernan, Catherine M Viscoli, Jennifer L Dearborn, et al.
JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
JAMA Neurology|September 1, 2015
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat EmptorMichelle Bowman, Michael Racke, John Kissel, et al.
JAMA Neurology|August 25, 2015
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide PlaquesSarah E Monsell, Walter A Kukull, Alex E Roher, et al.
JAMA Neurology|August 1, 2017
Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young AdultsOmar N Pathmanaban, Katherine V Sadler, Ian D Kamaly-Asl, et al.
JAMA Neurology|July 18, 2017
Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik StudyJie Ding, Sigurður Sigurðsson, Pálmi V Jónsson, et al.
JAMA Neurology|September 22, 2015
Association Between Atrial Fibrillation and Dementia in the General PopulationRenée F A G de Bruijn, Jan Heeringa, Frank J Wolters, et al.
JAMA Neurology|November 10, 2015
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen ActivatorYing Xian, Jerome J Federspiel, Maria Grau-Sepulveda, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|November 17, 2015
Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological CorrelationLaura Eisenmenger, Marie-Claire Porter, Christopher J Carswell, et al.
Pageof 177